Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant.

Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant. P T. 2019 Jun;44(6):340-375 Authors: Bahr R, Lopez A, Rey JA Abstract Intranasal esketamine for treatment-resistant depression. PMID: 31160868 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31160868?dopt=Abstract

Source: P and T - June 5, 2019 Category: Drugs & Pharmacology Tags: P T Source Type: research

More News: Depression | Drugs & Pharmacology